Ritlecitinib in Patients With Keloids or Those Undergoing Keloidectomy

NCT06373458 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Keloid

Interventions

DRUG: Ritlecitinib

Sponsor

Icahn School of Medicine at Mount Sinai

Collaborators

[object Object]